Yüklüyor......
Structural characterization of the maytansinoid–monoclonal antibody immunoconjugate, huN901–DM1, by mass spectrometry
Immunoconjugates are being explored as novel cancer therapies with the promise of target-specific drug delivery. The immunoconjugate, huN901–DM1, composed of the humanized monoclonal IgG(1) antibody, huN901, and the maytansinoid drug, DM1, is being tested in clinical trials to treat small cell lung...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Cold Spring Harbor Laboratory Press
2005
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2253466/ https://ncbi.nlm.nih.gov/pubmed/16081651 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1110/ps.051478705 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|